Tech Company Financing Transactions
Protedyne Funding Round
Allen & Company, Boston Community Venture Fund and Long River Ventures participated in a $10 million Series D funding round for Protedyne. The funding round was announced on 8/23/2005.
Transaction Overview
Company Name
Announced On
8/23/2005
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series D
Investors
Proceeds Purpose
Protedyne will use the proceeds of the Series D financing for working capital purposes, including enhancements to the Company's BioCube System product line and for new product development and expanded marketing activities.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1000 Day Hill Road
Windsor, CT 06095
USA
Windsor, CT 06095
USA
Phone
Website
Email Address
Not Recorded
Overview
Protedyne Corporation is headquartered in a 21,000 square-foot facility in Windsor, Connecticut. This facility houses the engineering team, the sales and marketing department, a contract services and demonstration laboratory, and a manufacturing warehouse.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Fran Tuttle
Chief Operating Officer
Roch Kelly
Chief Technical Officer
Peter Massaro
VP - Engineering
David Wilson
Browse more venture capital transactions:
Prev: 8/23/2005: Extraprise venture capital transaction
Next: 8/23/2005: SkyeTek venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs